ALX ONCOLOGY HLDGS INC's ticker is ALXO and the CUSIP is 00166B105. A total of 116 filers reported holding ALX ONCOLOGY HLDGS INC in Q3 2021. The put-call ratio across all filers is 0.35 and the average weighting 0.9%.
Quarter-by-quarter ownership
Value | Shares | Weighting | ||||
---|---|---|---|---|---|---|
Q2 2023 | $52,346 | 0.0% | 11,581 | 0.0% | 0.00% | – |
Q1 2023 | $52,346 | -100.0% | 11,581 | -12.6% | 0.00% | – |
Q2 2022 | $107,201,000 | -98.3% | 13,251 | -96.4% | 0.00% | -100.0% |
Q1 2022 | $6,179,535,000 | -18.4% | 365,653 | +3.8% | 0.00% | 0.0% |
Q4 2021 | $7,569,895,000 | -62.4% | 352,252 | +29.3% | 0.00% | -62.5% |
Q3 2021 | $20,114,811,000 | +33.2% | 272,337 | -1.4% | 0.01% | +33.3% |
Q2 2021 | $15,098,952,000 | +12.0% | 276,133 | +51.0% | 0.01% | 0.0% |
Q1 2021 | $13,484,096,000 | +371.0% | 182,860 | +450.6% | 0.01% | +500.0% |
Q4 2020 | $2,862,616,000 | – | 33,209 | – | 0.00% | – |
Download |
Other shareholders
Name | Shares | Value | Weighting ↓ |
---|---|---|---|
venBio Partners LLC | 9,699,925 | $715,272,000 | 67.97% |
Logos Global Management LP | 3,156,981 | $232,796,000 | 22.72% |
Vivo Capital, LLC | 4,220,048 | $311,186,000 | 10.94% |
Foresite Capital Management IV, LLC | 785,945 | $57,956,000 | 6.94% |
Foresite Capital Management V, LLC | 320,000 | $23,597,000 | 6.94% |
Board of Trustees of The Leland Stanford Junior University | 518,822 | $38,258,000 | 3.38% |
Cormorant Asset Management, LP | 881,770 | $65,022,000 | 1.45% |
Redmile Group, LLC | 978,600 | $72,162,000 | 1.02% |
SPHERA FUNDS MANAGEMENT LTD. | 130,351 | $9,612,000 | 0.74% |
Artal Group S.A. | 525,000 | $38,714,000 | 0.68% |